<https://ipscell.com/2014/08/great-news-fda-nod-for-viacyte-ind-of-diabetes-stem-cell-based-product/>
<http://schema.org/description>
"ViaCyte just got FDA approval for its investigational new drug (IND), paving the way to start a combined Phase I/II clinical trial for Diabetes."
<https://ipscell.com/2014/08/great-news-fda-nod-for-viacyte-ind-of-diabetes-stem-cell-based-product/>